Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county.
The incidence rate (IR) and case-fatality rate (CFR) of meningococcal disease increased during the late 1980s and early 1990s in North Jutland County, Denmark. We examined the hypothesis that phenotypic markers of Neisseria meningitidis are predictors of septicaemia with or without meningitis, rapid disease progress and fatal outcome of meningococcal disease and we studied whether changes in IR and CFR over time might be related to emergence or spread of certain phenotypes. This follow-up study was based on a complete registration of 413 cases of meningococcal disease in North Jutland County during 1980-99. Phenotypic markers included serogroup, serotype and serosubtype. A complete phenotype was available for 315 cases (76 %); 100 (32 %) strains were phenotype B : 15 : P1.7,16 and 31 (10 %) were C : 2a : P1.2,5. Septicaemia without meningitis was less common in cases with B : 15 : P1.7,16 and C : 2a : P1.2,5 strains. No association was found between phenotype and rapid disease progress. The overall CFR was 12 %. An increased CFR was associated with phenotypes B : 15 : P1.7,16 [odds ratio (OR) 2.8, 95 % confidence interval (CI) 1.2-18.5] and C : 2a : P1.2,5 (OR 5.2, 95 % CI 1.6-16.4) when compared with other phenotypes. The prevalence of B : 15 : P1.7,16 strains increased gradually during the study period and the CFR increased from 8 % during 1980-89 to 19 % during 1990-99, although the CFR for other phenotypes also increased. The CFR for C : 2a : P1.2,5 remained high ( approximately 20 %), but the contribution of this phenotype to the overall CFR decreased during the study period. In conclusion, phenotypes B : 15 : P1.7,16 and C : 2a : P1.2,5 were predictors of an increased CFR. The high prevalence of phenotype B : 15 : P1.7,16 contributed to increased overall IR and CFR during 1990-99.
Jensen
Elise Snitker
ES
Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark.
Schønheyder
Henrik C
HC
Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark.
Lind
Inga
I
Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark.
Berthelsen
Lene
L
Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark.
Nørgård
Bente
B
Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark.
Sørensen
Henrik Toft
HT
Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003718:Denmark / Q000453:epidemiology; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008585:Meningitis, Meningococcal / Q000382:microbiology / Q000401:mortality; D008589:Meningococcal Infections / Q000382:microbiology* / Q000401:mortality; D008875:Middle Aged; D009345:Neisseria meningitidis / Q000145:classification* / Q000235:genetics / Q000472:pathogenicity*; D010641:Phenotype; D018805:Sepsis / Q000382:microbiology* / Q000401:mortality; D012703:Serotyping; D016019:Survival Analysis